Organophosphate sensitive and insensitive carboxylesterases in human skin

E Heymann1, W Hoppe, A Krüsselmann

  • 1Arbeitsgruppe Gesundheitswissenschaften, University of Osnabrück, Germany.

Insights

Human skin contains at least four distinct carboxylesterases that metabolize aromatic esters. Organophosphate inhibitors like paraoxon reveal functional heterogeneity among these skin enzymes.

Area of Science:

  • Biochemistry
  • Dermatology
  • Enzymology

Background:

  • Carboxylesterases are crucial enzymes involved in metabolizing various xenobiotics and endogenous compounds.
  • Organophosphates, such as paraoxon and bis(4-nitrophenyl)phosphate (BNPP), are known inhibitors of B-esterase type carboxylesterases.
  • Understanding the specific carboxylesterases in human skin is important for assessing dermal exposure and metabolism of ester-containing compounds.

Purpose of the Study:

  • To investigate the influence of paraoxon and BNPP on human skin carboxylesterases.
  • To characterize the different carboxylesterase activities present in human skin homogenates.
  • To determine the sensitivity of various skin carboxylesterase isoenzymes to organophosphate inhibition.

Main Methods:

  • Human skin homogenates were prepared and assayed for carboxylesterase activity.
  • Isoelectric focusing (IEF) was used to separate and visualize different carboxylesterase isoenzyme bands.
  • Organophosphate inhibitors (paraoxon and BNPP) were applied to assess enzyme inhibition kinetics.
  • Anion exchange chromatography and Fast Protein Liquid Chromatography (FPLC) were employed for enzyme enrichment.

Main Results:

  • Human skin homogenates exhibited minimal paraoxon-cleaving or phosphodiesterase activity with BNPP.
  • IEF revealed three distinct zones of carboxylesterase activity, with varying sensitivities to organophosphates.
  • A major zone with carboxylesterase activity (pI 5.7-6.2) was rapidly and completely inhibited by paraoxon.
  • Another zone (pI 4.9) and a zone with 5 bands (pI 6.7-7.0) were insensitive to organophosphate inhibition, indicating functional heterogeneity.

Conclusions:

  • Human skin possesses at least four distinct carboxylesterases capable of hydrolyzing simple aromatic esters.
  • The identified carboxylesterases exhibit differential sensitivity to organophosphate inhibition, suggesting functional heterogeneity.
  • Specific carboxylesterase isoenzymes, particularly those in the pI range of 5.7-6.2 and at pI 4.9, can be enriched via chromatographic techniques.

Related Concept Videos

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
Cholinesterases: Distribution and Function01:22

Cholinesterases: Distribution and Function

Cholinesterases are a group of serine hydrolase enzymes that play a crucial role in the breakdown of choline esters. The two primary types of cholinesterases are acetylcholinesterases (AChEs) and butyrylcholinesterase (BuChEs), which differ in their distribution, function, and substrate specificity. AChEs, also known as true cholinesterases, specifically hydrolyze acetylcholine, while BuChEs, often referred to as pseudocholinesterases, can hydrolyze various choline esters, including...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Indirect-Acting Cholinergic Agonists: Pharmacokinetics01:22

Indirect-Acting Cholinergic Agonists: Pharmacokinetics

Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...